These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 19952980

  • 1. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T, Van Damme P, Lindblad N, Pfletschinger U, Radley D, Ryan D, Vuocolo S, Haupt RM, Guris D.
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [Abstract] [Full Text] [Related]

  • 2. Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel.
    Reisinger KS, Block SL, Collins-Ogle M, Marchant C, Catlett M, Radley D, Sings HL, Haupt RM, Garner EI, Protocol 025 Investigators.
    Pediatrics; 2010 Jun; 125(6):1142-51. PubMed ID: 20439595
    [Abstract] [Full Text] [Related]

  • 3. An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age.
    Kosalaraksa P, Mehlsen J, Vesikari T, Forstén A, Helm K, Van Damme P, Joura EA, Ciprero K, Maansson R, Luxembourg A, Sobanjo-ter Meulen A.
    Pediatr Infect Dis J; 2015 Jun; 34(6):627-34. PubMed ID: 25831420
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY, Hwang HS, Kim JH, Kim HH, Lee HS, Chung EH, Park SE, Ma SH, Chang JK, Guitton F, Ortiz E, Kang JH.
    Vaccine; 2011 Feb 11; 29(8):1551-7. PubMed ID: 21215828
    [Abstract] [Full Text] [Related]

  • 5. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.
    Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526
    [Abstract] [Full Text] [Related]

  • 6. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O.
    Hum Vaccin; 2010 Oct 25; 6(10):829-34. PubMed ID: 20864810
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
    Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A.
    Pediatr Infect Dis J; 2011 Dec 25; 30(12):e225-34. PubMed ID: 21817954
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
    Garcia-Sicilia J, Schwarz TF, Carmona A, Peters K, Malkin JE, Tran PM, Behre U, Iturbe EB, Catteau G, Thomas F, Dobbelaere K, Descamps D, Dubin G, HPV Vaccine Adolescent Study Investigators Network.
    J Adolesc Health; 2010 Feb 25; 46(2):142-51. PubMed ID: 20113920
    [Abstract] [Full Text] [Related]

  • 9. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP.
    Pediatr Infect Dis J; 2008 Apr 25; 27(4):341-6. PubMed ID: 18316985
    [Abstract] [Full Text] [Related]

  • 10. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M, He S, Lai S, Petrecz M, Yuan G, Liu GF, Mikviman E, Heaton PM, Panzer F, Rose T, Koller DY, Van Damme P, Schödel F.
    Pediatr Infect Dis J; 2009 Mar 25; 28(3):177-81. PubMed ID: 19209092
    [Abstract] [Full Text] [Related]

  • 11. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME, Casey JR, Francis AB, Marsocci SM, Murphy M, Hoeger W, Cleary C.
    Clin Pediatr (Phila); 2006 Sep 25; 45(7):613-20. PubMed ID: 16928838
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.
    McNeil SA, Noya F, Dionne M, Predy G, Meekison W, Ojah C, Ferro S, Mills EL, Langley JM, Halperin SA.
    Vaccine; 2007 Apr 30; 25(17):3464-74. PubMed ID: 17270320
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.
    Pediatrics; 2006 Apr 30; 117(4):1084-93. PubMed ID: 16585302
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R, Galtier F, Richard P, Baudin M.
    Vaccine; 2014 Jun 30; 32(31):3942-9. PubMed ID: 24852717
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 30; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.